Neurocrine Biosciences, Inc. (LON:0K6R)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,934	11,039	10,163	9,530	5,967	6,559
Market Cap Growth	8.62%	8.62%	6.65%	59.70%	-9.03%	-12.25%
Enterprise Value	7,498	10,287	9,518	9,101	5,736	6,246
Last Close Price	80.16	108.92	104.04	98.59	63.33	70.46
PE Ratio	29.10	40.49	51.85	74.32	90.18	21.99
PS Ratio	4.22	5.87	6.86	7.71	7.13	8.56
PB Ratio	3.84	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	3.90	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	-	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	-	23.21	33.20	33.83	31.50	39.19
EV/Sales Ratio	4.24	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	15.31	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	17.12	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	16.85	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.19	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.89	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.68	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	15.99	15.99	16.48	14.85	11.71	12.59
Quick Ratio	3.06	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.40	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.16%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	10.46%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	12.68%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	18.20%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	3.44%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	5.61%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	-2.67%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.